Center for Biopharmaceutical Operations Workshop

• May 21, 2008: 9:00am - 5:00pm

Please join us for a day-long Biopharmaceutical Operations workshop to examine critical issues in biopharmaceutical operations, featuring key decision makers from major local and national biopharmaceutical firms, as well as members of the UC Community. \

More information and registration is currently available at http://www.acteva.com/organizer/act_display.cfm?eventid=151953.

 

The goal of this workshop is to develop a focused list of research issues and practical next steps to further the state of the art in biopharmaceutical operations. The workshop will include a keynote address by Pat Yang, Genentech Executive Vice President of Product Operations, a panel discussions with representatives of Bayer and Biomarin, and presentations about past and current biopharmaceutical industry projects. Please note that a limited number of faculty members are subsidized by UC Discovery.

 

Current agenda:

 

8:30 a.m. Introduction and Welcome

9:00 a.m. Bayer Planner Engine Discussion
Prasad Saraph of Bayer
Rob Leachman (UCB)

9:25 a.m. Genentech Simulation System Discussion
Arden Yang of Genentech
Lee Schruben (UCB)

9:50 a.m. Demand/ Capacity Analysis Discussion
Darren Johnson of Genentech
Phil Kaminsky (UCB)

10:15 a.m. Break

10:30a.m. Breakout Sessions

11:30 a.m. Benchmarking
Rob Leachman - UCB
12:00 p.m. Lunch

1:00 p.m. Student Research Plan Presentations

1:45 p.m. Awards and Panel Discussion
Chair: Phil Kaminsky
Chris Horan: VP, Planning, Distribution & Logistics, Genentech
Joerg Heindrich: VP, Global Supply Chain, Product Supply, Bayer Healthcare
Tue Nguyen: VP Operations, Institute for One World Health
Andy Rammelmeier : VP, Manufacturing and Process Development, Biomarin
Brian Maiorella: UCB

2:45 p.m. Break

3:00 p.m. Keynote speaker
Pat Yang, Executive VP of Operations, Genentech

4:00 p.m. Outcome Summary + Additional Discussion

4:30 p.m. Close of Workshop

 

-=-------------------

Background: UC Berkeley has been developing the Center for Biopharmaceutical Operations (CBO) to bring together academic researchers from throughout the University of California with diverse expertise and industrial experience and biopharmaceutical professionals. The goal of CBO is to advance the state of the art of biopharmaceutical operations by facilitating collaboration between academia and industry, conducting biopharmaceutical operations benchmarking studies, establishing projects to improve the current body of research and operational performance in industry, developing and providing educational seminars, and providing industry with world class employees.